Opinion
Video
Author(s):
Urologists review clinical trials investigating new imaging options in kidney cancer, including the ZIRCON study looking at girentuximab.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Subcutaneous nivolumab approved in EU, Canada for solid tumors
Patient selection for cytoreductive nephrectomy in 2025
Telehealth in urologic cancer: Lessons learned from the COVID-19 pandemic
Perioperative lenvatinib/pembrolizumab shows promise in non-metastatic ccRCC
The importance of federal funding in cancer research: A call to action
FDA updates in urology: March 2025
PEACE-3 data for radium-223/enzalutamide published in Annals of Oncology
Phase 2 trial launches of combination immunotherapy for mCRPC
Study findings highlight gender gaps in oncology authorship and citation
ORIC-944 shows promise in combination with AR inhibitors in mCRPC